| |
|
|
|
AC Immune SA  
|
|
5.35 -0.06 (-0.01%) |
09-17 16:00 |
|
Open: |
5.41 |
Pre close: |
5.41 |
Target:
|
6.39 
|
|
High: |
5.49 |
Low: |
5.26 |
Resistance:
|
5.47
5.83
|
|
Volume: |
48,561 |
Market Cap: |
361M |
Support:
|
4.89
4.07
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.27
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
5.25 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
5.30 |
Stochastic Oscillator |
%K(14,3):
|
63.62 |
|
MA(250): |
6.67 |
%D(3): |
51.02 |
|
Average Volume(K) |
3-Month: |
10874
|
52-Week |
High:
|
12.50 |
|
10-Days: |
19708 |
Low: |
3.25 |
|
RSI |
RSI(14):
|
51.74 |
Change(%): |
-33.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
10.0 |
Shares Out. (M) |
67.56 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
5.7 |
Shares Float (M) |
24.60 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
51.67 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
-25.5 |
% Held by Institutions |
38.19 |
|
Forward EPS |
-0.970 |
Gross Profit (p.s.) |
-0.549 |
Shares Short (K) |
483 |
|
Book Value (p.s.) |
2.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-9.73 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.79 |
|
Profit Margin |
23.02 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
